JYSELECA: convenient oral formulation, once-daily tablet1

Reference: 1. Feagan BG, Danese S, Loftus EV Jr, et al. Lancet 2021;397:2372–2384. 

JYSELECA should only be used if no suitable treatment alternatives are available in:

200 No dose adjustment is required for:     

100 JYSELECA 100 mg is recommended for:

The lowest effective dose is recommended for:

JYSELECA is not recommendeda for: 

JYSELECA is contraindicated in:

Additional considerations: 

aJYSELECA has not been studied in these populations; no data are available.

CrCl, creatinine clearance; CV, cardiovascular; CVD, cardiovascular disease; MACE, major adverse cardiovascular event; VTE, venous thromboembolism.

INDICATIONS: JYSELECA is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.

GB-IBD-FIL-202301-00012 | Date of preparation: October 2023